tirzepatide effect on kidneys improves kidney outcomes in T2DM with increased CV risk Tirzepatide for Heart Failure Shows

Switching requires clinician oversight, careful dose titration, and monitoring for side effects

People with a history of pancreatitis should be evaluated thoroughly, as there is ongoing discussion regarding potential links between GLP-1 receptor agonists and pancreatic inflammation, though evidence remains inconclusive

1:500 dilution), rabbit anti-VIM (Abcam, RRID: AB_10562134

Amino acid metabolism, redox balance and epigenetic regulation in cancer

Results were normalized to that of IgG control groups, as described previously 51

Senekowitsch, S., Wietkamp, E., Grimm, M., Schmelter, F., Schick, P., Kordowski, A., Sina, C., Otzen, H., Weitschies, W., & Smollich, M